Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tango Therapeutics Inc (NQ: TNGX )

5.150 -0.285 (-5.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tango Therapeutics Inc

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Analyst Scoreboard: 4 Ratings For Tango Therapeutics
Via Benzinga
Tango Therapeutics to Participate in Upcoming Investor Conferences
From Tango Therapeutics, Inc.
Via Business Wire
Analyst Expectations For Tango Therapeutics's Future
Via Benzinga
Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
From Tango Therapeutics, Inc.
Via Business Wire
Expert Outlook: Tango Therapeutics Through The Eyes Of 6 Analysts
Via Benzinga
Forecasting The Future: 4 Analyst Projections For Tango Therapeutics
Via Benzinga
Recap: Tango Therapeutics Q4 Earnings
Via Benzinga
Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
From Tango Therapeutics, Inc.
Via Business Wire
Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity
Tango Therapeutics halts its TNG348 program due to liver toxicity issues found in dose escalation studies. The company will now focus on its PRMT5 program and plans to update on TNG908 and TNG462 later... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Tango Therapeutics Announces Discontinuation of TNG348 Program
From Tango Therapeutics
Via Business Wire
Tango Therapeutics: Q3 Earnings Insights
Via Benzinga
TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q1 2024
TNGX stock results show that Tango Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
From Tango Therapeutics, Inc.
Via Business Wire
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Tango Therapeutics, Inc.
Via Business Wire
TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q4 2023
TNGX stock results show that Tango Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
From Tango Therapeutics, Inc.
Via Business Wire
Tango Therapeutics to Participate in Upcoming Investor Conferences
From Tango Therapeutics, Inc.
Via Business Wire
Pancreatic Cancer Treatments Poised for Major Advances in 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:INCY),(NASDAQ:TNGX),(NASDAQ:RYZB),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc. 
Via Benzinga
Why Shares of Tango Therapeutics Are Dropping Monday
Another company's buyout helped drive up the price last week. This week, investors started out by selling the stock. 
Via The Motley Fool
Chart Of The Day: Tango Therapeutics - What Happens When The FDA Gives A Thumbs UP!
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. 
Via Talk Markets
Exposures Product Safety
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Why Shares of Tango Therapeutics Climbed This Week
The company got the go-ahead last week from the FDA for a drug's IND. 
Via The Motley Fool
Exposures Product Safety
Oracle, Sight Sciences And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.